Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-25-004406)

Filing Details

Accession Number:: 0001415889-25-004406
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-02-18 16:20:28
Reporting Period:: 2025-02-13

Filing Date:: 2025-02-18
Accepted Time:: 2025-02-18 16:20:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1817229	Vor Biopharma Inc.	VOR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1789076	C. Eyal Attar	C/O Vor Biopharma Inc. 100 Cambridgepark Drive, Suite 101 Cambridge MA 02140	Chief Medical Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2025-02-13	2,227	$1.42	126,625	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The transaction was pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024.